Home › Diabetic Eye Problems › California
Diabetic Eye Problems clinical trials in California
7 studies for Diabetic Eye Problems are looking for participants at sites in California.
Cities in California
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
- Global Research Management ( Site 0066), Glendale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07705555Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
- California Retina Consultants - Bakersfield /ID# 282990, Bakersfield
- Retina-Vitreous Associates Medical Group - Beverly Hills /ID# 282995, Beverly Hills
- The Retina Partners /ID# 274741, Encino
- and 6 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07592273A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
- Global Research Management, Glendale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07588100Village-Integrated Eye Worker Trial II
- University of California, San Francisco, San Francisco
RecruitingHealthy volunteers welcome
Ages 60 and older · All sexes · Updated Jun 9, 2026 · NCT03752840Strategies for Improving Linkage-to-Care After Eye Disease Screening
- University of California, San Francisco, San Francisco
Recruiting
Ages 60 and older · All sexes · Updated Apr 29, 2026 · NCT06943599High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
- Retina Consultants of Orange County, Fullerton
RecruitingPhase 4
Ages 21 and older · All sexes · Updated Jul 10, 2025 · NCT06662994A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
- Retina-Vitreous Associates Medical Group, Beverly Hills
- Stanford Byers Eye Institute, Palo Alto
- California Retina Consultants- Santa Barbara, Santa Barbara
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 18, 2025 · NCT06770933From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.